Jessie Hanrahan's most recent trade in Solid Biosciences Inc was a trade of 11,862 Common Stock done . Disclosure was reported to the exchange on Dec. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 11,862 | 31,143 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 11,862 | 11,863 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Hanrahan Jessie | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 5.11 per share. | 02 Dec 2025 | 4,483 | 26,660 (0%) | 0% | 5.1 | 22,908 | Common Stock |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 142,500 | 142,500 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 71,250 | 71,250 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 8,125 | 22,360 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 8,125 | 24,375 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 3,079 | 19,281 (0%) | 0% | 4.0 | 12,193 | Common Stock |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 110,500 | 110,500 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 11,862 | 23,725 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 11,862 | 18,845 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Hanrahan Jessie | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 02 Dec 2024 | 4,610 | 14,235 (0%) | 0% | 5.6 | 25,822 | Common Stock |
| Solid Biosciences Inc | Hanrahan Jessie | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 65,000 | 65,000 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Hanrahan Jessie | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 32,500 | 32,500 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 11,862 | 35,587 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 11,862 | 11,862 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 2.78 per share. | 02 Dec 2023 | 4,879 | 6,983 (0%) | 0% | 2.8 | 13,562 | Common Stock |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 94,899 | 94,899 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Jessie Hanrahan | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 47,449 | 47,449 | - | - | Restricted Stock Units |